U.S. markets open in 5 hours 46 minutes
  • S&P Futures

    4,171.25
    -5.00 (-0.12%)
     
  • Dow Futures

    34,002.00
    -79.00 (-0.23%)
     
  • Nasdaq Futures

    14,039.00
    +9.50 (+0.07%)
     
  • Russell 2000 Futures

    2,249.80
    -9.20 (-0.41%)
     
  • Crude Oil

    62.97
    -0.16 (-0.25%)
     
  • Gold

    1,782.20
    +2.00 (+0.11%)
     
  • Silver

    25.98
    -0.13 (-0.50%)
     
  • EUR/USD

    1.1993
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.5730
    0.0000 (0.00%)
     
  • Vix

    17.02
    +0.45 (+2.72%)
     
  • GBP/USD

    1.3855
    +0.0016 (+0.11%)
     
  • USD/JPY

    108.3660
    -0.4170 (-0.38%)
     
  • BTC-USD

    57,289.57
    +465.48 (+0.82%)
     
  • CMC Crypto 200

    1,305.11
    -86.60 (-6.22%)
     
  • FTSE 100

    7,023.38
    +3.85 (+0.05%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

Medicine Man Denver Becomes The Latest Firm To Split From Schwazze

Anthony Noto
·2 min read

Cannabis cultivator Medicine Man Denver is terminating a term sheet agreement with Schwazze (OTCQX: SHWZ). The split will be effective as of Aug. 20.

Denver-based Schwazze previously did business as Medicine Man Technologies Inc. before rebranding in April.

What To Know: "The recent decision to terminate our agreement with Schwazze is the right decision for both companies," said Sally Vander Veer, CEO of Medicine Man Denver. "We look forward to continuing to build Medicine Man Denver's footprint within our state in order to serve our customers, employees, and communities in which we work."

Medicine Man Denver has yet to confirm a new production partner.

According to Medicine Man co-founder Andy Williams, Medicine Man will begin a new search for what it calls "a quality partner" that has the desire to have a presence in the Colorado market.

"We wish them best as we each move forward with our respective businesses,” Schwazze said in a prepared statement.

Why It's Important: Schwazze CEO Justin Dye has spoken to Benzinga at length about the company's $170 million M&A strategy. And while several acquisitions are still in the works, including a pending deal with Star Buds, Medicine Man Denver marks the sixth purchase agreement that has fallen through under Dye's watch.

Medically Correct, also based in Denver, terminated an acquisition agreement with Schwazze just a few weeks ago.

“Our decision to terminate this acquisition comes as we shift our focus toward the development and national expansion of our new brands Quiq, Nove and Clear Creek Extracts,” Medically Correct president Bob Eschino said at the time.

Medically Correct, founded in 2010, owns a variety of THC and CBD brands, including a line of chocolates gummies and mints, among others.

Schwazze also canceled a $12 million purchase of cannabis cultivator Los Sueños Farms, as well as a $3.75 million acquisition of Dabble Extracts. Before that, dispensary company High Country Supply rescinded a $12.5 million sale to Schwazze.

Dispensary group Strawberry Fields also terminated its $31 million sale to Schwazze on April 20 — the same day Medicine Man Technologies confirmed the name change.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.